CJC-1295 No DAC
A$399
CJC-1295 No DAC
A growth hormone releasing hormone (GHRH) analogue that stimulates the pituitary to release growth hormone in a pulsatile, physiological manner.
Commonly considered for
Natural GH optimisation
Muscle recovery
Fat metabolism
Sleep quality
Anti-ageing support
How it works
Binds to GHRH receptors on the pituitary gland, triggering natural GH release. The 'No DAC' version provides shorter-acting pulses that mimic natural secretion patterns.
Typical Use
Best administered 2-3 times daily, often before bed and upon waking. Typically combined with a GHRP like Ipamorelin.
Often stacked with
Storage
Store unopened pens refrigerated at 2–8°C. Opened/activated pens should be used within 28 days when kept refrigerated. Do not freeze. Keep away from direct sunlight.
Practitioner Review
This compound is supplied exclusively following a Zenith assessment, bloodwork panel, and practitioner sign-off. Every supply includes a protocol card and dosing guide.
Research context: Well-studied GHRH analogue with established safety profile in clinical settings.
Frequently asked
Best administered 2-3 times daily, often before bed and upon waking. Typically combined with a GHRP like Ipamorelin.
Binds to GHRH receptors on the pituitary gland, triggering natural GH release. The 'No DAC' version provides shorter-acting pulses that mimic natural secretion patterns.
CJC-1295 No DAC is commonly used alongside Ipamorelin, BPC-157, TB-500.
All Zenith compounds are supplied exclusively following assessment, bloodwork, and practitioner review.
Regulatory & safety information
CJC-1295 No DAC is supplied subject to suitability assessment and applicable UAE regulatory requirements. Information provided is general and is not a substitute for professional medical advice, diagnosis or treatment.
Always consult a qualified healthcare professional before starting, changing or stopping any product, particularly if you are pregnant, breastfeeding, under 18, or managing a medical condition.
Why treatment isn't self-selected
Treatment decisions need context.
Selecting a treatment option is the starting point. What's clinically appropriate for you is determined by three things together.
Your bloodwork
Relevant biomarkers help identify which treatment options may be appropriate — and which should be avoided.
Your health history
Existing conditions, medications and goals are considered alongside your results, not in isolation.
Practitioner review
A licensed practitioner reviews every request before anything is approved, dosed or supplied.
Before you choose
Your bloodwork can change the conversation.
Recent bloodwork gives your practitioner more to work with — helping identify what may be appropriate, what should be avoided, and where a different option might be better suited to your results.
Already uploaded results? Your practitioner reviews them alongside any treatment request — no need to repeat information.
Optional at this stage. Required before final approval.
Ready to move forward?
Three ways to continue.
Upload your bloodwork
Already have recent results? Upload them so your practitioner can review your treatment request in context.
Purchase a blood test
No recent results? Order an at-home Zenith blood test to establish your baseline before choosing treatment.
Start your assessment
Begin the health assessment now — you can add bloodwork and treatment selections at any stage.
Purchase
CJC-1295 No DAC
Supplied following assessment, bloodwork and practitioner review.
Price
A$399
Ready to start?
Complete an assessment and get access to CJC-1295 No DAC through a tailored protocol.